CLDN18 and cancer: The findings to date indicate that CLDN18 is regulated at the transcriptional level through the methylation of CpG islands, the PKC pathway, the ERK/MAPK pathway, and the HER signalling pathway and is regulated at the posttranscriptional level by miRNAs, providing new approaches for CLDN18-based cancer therapy.